Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionPinnacle Wealth Planning Services, Inc.
Latest Disclosed Ownership1,550 shares
Latest Disclosed Value $ 691,914
Pinnacle Wealth Planning Services, Inc. reports 2.11% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 11, 2026 - Pinnacle Wealth Planning Services, Inc. filed a 13F-HR form disclosing ownership of 1,550 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $692,137 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,518 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 2.11% during the quarter. The current value of the position is $684,697 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,550 32 2.11 692 0.58 0.0715
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,518 138 10.00 688 27.22 0.0718
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICA COM 92532F100 1,380 512 58.99 540 39.90 0.0633
2025-08-11 2025-06-30 13F VERTEX PHARMACEUTICA COM 92532F100 868 -218 -20.07 386 -26.62 0.0508
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICA COM 92532F100 1,086 57 5.54 527 27.05 0.0792
2025-02-27 2024-12-31 13F/A-1 VERTEX PHARMACEUTICA COM 92532F100 1,029 -74 -6.71 414 -19.14 0.0623
2025-02-06 2024-12-31 13F VERTEX PHARMACEUTICA COM 92532F100 1,029 -74 414 0.0579
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,103 0 0.00 513 -0.78 0.0697
2024-08-09 2024-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,103 1 0.09 517 12.17 0.0739
2024-05-10 2024-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,102 -1 -0.09 461 2.68 0.0675
2024-02-08 2023-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,103 -1 -0.09 449 16.97 0.0705
2023-11-08 2023-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,104 -9 -0.81 384 -2.05 0.0633
2023-08-07 2023-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,113 -1 -0.09 392 11.71 0.0633
2023-05-03 2023-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,114 12 1.09 351 10.06 0.0583
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,102 -116 -9.52 318 -9.92 0.0565
2022-11-09 2022-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,218 -17 -1.38 353 1.44 0.0653
2022-08-03 2022-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,235 258 26.41 348 36.47 0.0625
2022-04-20 2022-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 977 -42 -4.12 255 13.84 0.0465
2022-01-21 2021-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,019 1,019 224 0.0438
2021-08-02 2021-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 0 -1,090 -100.00 0 -100.00
2021-04-29 2021-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,090 137 14.38 235 4.44 0.0603
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 953 16 1.71 225 -11.76 0.0538
2020-11-03 2020-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 937 -7 -0.74 255 -6.93 0.0842
2020-07-27 2020-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 944 -69 -6.81 274 14.17 0.0890
2020-05-11 2020-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,013 1,013 240 0.1140
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.